Terms: = Head and neck cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Diagnosis
23 results:
1. Single-cell sequencing reveals SATB2/notch1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract] [Full Text] [Related]
2. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.
Ju G; Yao Z; Zhao Y; Zhao X; Liu F
Sci Rep; 2023 Jun; 13(1):10020. PubMed ID: 37340028
[TBL] [Abstract] [Full Text] [Related]
3. Increased retinoic acid signaling decreases lung metastasis in salivary adenoid cystic carcinoma by inhibiting the noncanonical notch1 pathway.
Zhou MJ; Yang JJ; Ma TY; Feng GX; Wang XL; Wang LY; Ge YZ; Gao R; Liu HL; Shan L; Kong L; Chen XH
Exp Mol Med; 2023 Mar; 55(3):597-611. PubMed ID: 36879115
[TBL] [Abstract] [Full Text] [Related]
4. Thyroid carcinoma metastases to central nervous system and vertebrae.
Kleinschmidt-DeMasters B; Marshall C
Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
[TBL] [Abstract] [Full Text] [Related]
5. Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation.
Feeney L; Hapuarachi B; Adderley H; Rack S; Morgan D; Walker R; Rauch R; Herz E; Kaye J; Harrington K; Metcalf R
Oral Oncol; 2022 Oct; 133():106028. PubMed ID: 35952580
[TBL] [Abstract] [Full Text] [Related]
6. The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
Yang X; Song H; Ji T; Du G; Liu W
Oral Oncol; 2022 Jul; 130():105924. PubMed ID: 35594773
[TBL] [Abstract] [Full Text] [Related]
7. The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
Yang X; Xu X; Zhang C; Ji T; Wan T; Liu W
Oral Oncol; 2022 May; 128():105846. PubMed ID: 35358785
[TBL] [Abstract] [Full Text] [Related]
8. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract] [Full Text] [Related]
9. Exome sequencing identifies new somatic alterations and mutation patterns of tongue squamous cell carcinoma in a Chinese population.
Zhang H; Song Y; Du Z; Li X; Zhang J; Chen S; Chen F; Li T; Zhan Q
J Pathol; 2020 Aug; 251(4):353-364. PubMed ID: 32432340
[TBL] [Abstract] [Full Text] [Related]
10. Long-term outcomes and clinicogenomic correlates in recurrent, metastatic adenoid cystic carcinoma.
Hanna GJ; Bae JE; Lorch JH; Schoenfeld JD; Margalit DN; Tishler RB; Haddad RI; Chau NG
Oral Oncol; 2020 Jul; 106():104690. PubMed ID: 32283496
[TBL] [Abstract] [Full Text] [Related]
11. Central Nervous System-Invading Eccrine Gland Carcinoma: A Clinicopathologic Case Series and Literature Review.
Gupta S; Hulsbergen AFC; Segar DJ; Hauser BM; Bernstock JD; Nazarian RM; Lawrence DP; Nahed BV; Broekman MLD; Smith TR
World Neurosurg; 2020 Jun; 138():e17-e25. PubMed ID: 32142948
[TBL] [Abstract] [Full Text] [Related]
12. CDK4, CDK6, cyclin D1 and notch1 immunocytochemical expression of oral brush liquid-based cytology for the diagnosis of oral leukoplakia and oral cancer.
Kujan O; Huang G; Ravindran A; Vijayan M; Farah CS
J Oral Pathol Med; 2019 Aug; 48(7):566-573. PubMed ID: 31172614
[TBL] [Abstract] [Full Text] [Related]
13. A review of the most promising biomarkers for early diagnosis and prognosis prediction of tongue squamous cell carcinoma.
Hussein AA; Forouzanfar T; Bloemena E; de Visscher J; Brakenhoff RH; Leemans CR; Helder MN
Br J Cancer; 2018 Sep; 119(6):724-736. PubMed ID: 30131545
[TBL] [Abstract] [Full Text] [Related]
14. Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.
Xie M; Wei S; Wu X; Li X; You Y; He C
Lung Cancer; 2018 Jul; 121():41-47. PubMed ID: 29858025
[TBL] [Abstract] [Full Text] [Related]
15. Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer.
Cavalieri S; Perrone F; Miceli R; Ascierto PA; Locati LD; Bergamini C; Granata R; Alfieri S; Resteghini C; Galbiati D; Busico A; Paielli N; Patuzzo R; Maurichi A; Gallino G; Ruggeri R; Mariani L; Palla M; Licitra L; Bossi P
Eur J Cancer; 2018 Jul; 97():7-15. PubMed ID: 29734047
[TBL] [Abstract] [Full Text] [Related]
16. CASTLE tumor of the parotid: First documented case, literature review, and genetic analysis of the cancer.
Wong EHC; Tetter N; Tzankov A; Muller L
Head Neck; 2018 Jan; 40(1):E1-E4. PubMed ID: 29120527
[TBL] [Abstract] [Full Text] [Related]
17. Diffuse Staining for Activated notch1 Correlates With notch1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
[TBL] [Abstract] [Full Text] [Related]
18. Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.
Jo VY; Chau NG; Hornick JL; Krane JF; Sholl LM
Mod Pathol; 2017 May; 30(5):650-659. PubMed ID: 28084339
[TBL] [Abstract] [Full Text] [Related]
19. Activating notch1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to notch1 Inhibitors.
Ferrarotto R; Mitani Y; Diao L; Guijarro I; Wang J; Zweidler-McKay P; Bell D; William WN; Glisson BS; Wick MJ; Kapoun AM; Patnaik A; Eckhardt G; Munster P; Faoro L; Dupont J; Lee JJ; Futreal A; El-Naggar AK; Heymach JV
J Clin Oncol; 2017 Jan; 35(3):352-360. PubMed ID: 27870570
[TBL] [Abstract] [Full Text] [Related]
20. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
[TBL] [Abstract] [Full Text] [Related]
[Next]
